Vor Biopharma Cash Flow Statement (2020-2026) | VOR

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-19.25M-18.97M-23.46M-22.98M-24.97M-26.63M-29.98M-30.43M-33.47M-28.66M-32.44M-27.91M-29.21M-32.40M-34.17M-283.94M-26.41M-33.27M-31.34M-44.43M
Depreciation and Depletion (Quarter)
0.30M0.43M0.40M0.60M0.90M0.62M0.84M0.90M0.90M0.89M0.94M0.90M0.90M0.80M0.80M2.10M0.00M0.04M0.03M0.04M
Share-based Compensation (Quarter)
1.15M1.20M1.75M1.74M3.33M16.56M0.27M4.24M3.16M-10.28M0.18M2.79M2.26M1.71M1.93M1.84M8.03M15.83M8.87M107.30M
Gains from Investment Securities (Quarter)
1,299.92M790.46M-1756.02M188.36M19.30M
Cash from Operations (Quarter)
-17.34M-17.59M-22.90M-24.99M-18.90M-18.35M-24.27M-24.10M-27.90M-24.03M-30.46M-21.85M-23.29M-24.06M-31.07M-35.18M-53.66M-22.80M-38.25M-25.38M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.30M0.43M0.40M0.60M0.90M0.62M0.84M0.90M0.90M0.89M0.94M0.90M0.90M0.80M0.80M2.10M0.00M0.04M0.03M0.04M
Change in Working Capital
Change in Accured Expenses (Quarter)
1.09M0.07M-0.72M-0.75M0.93M1.66M-0.09M0.11M2.66M0.17M-2.48M0.55M0.48M3.69M-1.37M1.10M5.00M6.21M-9.10M8.80M
Other Working Capital Changes (Quarter)
-0.70M-0.72M-0.73M-6.31M-2.00M-1.42M-0.73M-1.00M-0.92M-0.94M-0.92M-0.92M-0.97M-1.02M-1.05M-1.28M-0.02M-0.06M-0.06M-0.06M
Investing Activities
Capital Expenditures (Quarter)
2.58M-2.53M2.01M5.83M-7.79M-0.02M0.00M0.49M0.47M-0.89M0.11M0.01M0.03M0.07M0.38M0.24M0.31M0.05M0.12M
Change in Acquisitions & Divestments (Quarter)
13.00M21.43M30.00M49.00M41.00M27.00M54.00M53.00M0.00M-0.00M5.00M13.31M42.59M
Cash from Investing Activities (Quarter)
-8.49M-5.95M-7.05M-2.70M12.70M-97.04M6.50M13.64M40.54M10.34M43.97M52.99M-0.03M-0.07M-0.23M0.65M-0.24M-48.97M-263.24M-36.53M
Financing Activities
Other financing activities (Quarter)
-188.95M188.95M0.20M0.10M0.23M0.01M174.40M75.00M
Change in Capital Stock
Shares Issued (Quarter)
2.48M5.09M2.55M1.91M0.43M6.47M1.15M0.67M0.97M8.29M3.13M1.89M2.46M0.46M2.99M7.51M1.74M6.61M7.02M7.55M
Net Equity Issued and Repurchased (Quarter)
3.84M0.11M3.62M0.58M0.39M-0.01M0.28M-0.09M0.11M-0.02M20.26M49.85M
Misc.
Cash from Financing Activities (Quarter)
0.20M0.31M0.20M0.60M4.08M112.26M2.52M0.22M0.18M0.03M0.10M-0.03M0.04M53.29M-0.61M175.06M21.55M307.80M74.87M-0.11M
Change in Cash (Quarter)
-25.63M-23.23M-29.76M-27.09M-2.12M-3.12M-15.25M-10.24M12.81M-13.67M13.60M31.11M-23.28M29.15M-31.90M140.53M-32.36M236.02M-226.61M-62.02M
Free Cash Flow (Quarter)
-19.93M-15.05M-24.91M-30.82M-11.12M-18.33M-24.27M-24.59M-28.36M-23.14M-30.58M-21.86M-23.32M-24.14M-31.07M-35.57M-53.91M-23.11M-38.29M-25.50M
Net Cash Flow (Quarter)
-25.63M-23.23M-29.76M-27.09M-2.12M-3.12M-15.25M-10.24M12.81M-13.67M13.60M31.11M-23.28M29.15M-31.90M140.53M-32.36M236.02M-226.61M-62.02M